Washington, DC–(BUSINESS WIRE)–Today, Medscape Medical News (MNN) is highlighting the importance of the right diagnosis and treatment of patients with inflammatory bowel disease (IBD).
This is particularly important given that many patients with IBD may also have celiac disease, an autoimmune disease that can cause food intolerances, digestive problems and gastrointestinal distress.
Celiac disease is a chronic autoimmune disease characterized by the production of gluten, a protein that can bind to the lining of the small intestine, causing the intestines to be unable to absorb nutrients and leading to an inflammatory response.
This can cause inflammation of the intestinal lining and symptoms including bloating, gas, abdominal pain and diarrhea.
The condition is also known as Crohn’s disease, and the symptoms of it are often related to ulcerative colitis, Crohn disease, or ulcer and ulcer-associated diarrhea.
It is not known whether this condition is linked to gluten and IBD, but some studies have suggested that it may.
For these patients, the first step is to diagnose IBD.
The disease usually starts with symptoms that are similar to other inflammatory bowel diseases such as ulceratives colitis or Crohn sitis, which can also cause abdominal pain, bloating and diarrhea, according to the National Institute of Allergy and Infectious Diseases (NIAID).
The condition can progress to more serious symptoms that can include constipation, diarrhea and gas, and can last up to six months.
Once diagnosed, it is important to be seen immediately by a gastroenterologist, as these conditions can require hospitalization, according, to the Mayo Clinic.
To manage symptoms, the doctor may recommend medications, such as oral rehydration salts, intravenous fluids and intravenous antibiotics.
The treatments can help ease symptoms and improve symptoms.
Celiac patients who are diagnosed with IBS are advised to have a stool test to make sure that the disease is not causing their symptoms.
For people with IBB, the most important diagnosis is to see the physician.
If the doctor doesn’t believe the diagnosis, they may prescribe medication, such with the probiotics, that can improve symptoms, according the Mayo Center for Celiac Disease.
To find out if the condition is associated with gluten and gluten sensitivity, follow these steps: 1.
Get a stool sample from the patient.
The stool sample should be taken in the doctor’s office.
Take a blood sample.
If you can’t see the stool sample, a stool biopsy is recommended to confirm the diagnosis.
Get an intestinal biopsy.
The intestinal biopsies are usually done in a lab.
The doctor may also want to test the patient’s serum for gluten.
If they have a history of gastrointestinal symptoms, they should be diagnosed with gluten sensitivity.
Talk to your gastroenterology doctor.
Follow up with your gastroinformatics specialist.
If there is no clear cause for the symptoms, your gastroendoscopy may be necessary.
If this test is negative, the patient should be treated with probiotics.
The probiotics are usually taken as tablets that are mixed with diet.
It takes at least two weeks for the probiotic to start to help.
Celias test is usually done at least one month after the last stool sample and may also be done after the patient has a bowel movement.
If it is positive, the probiotics treatment will continue.
If a positive result, the treatment may need to be repeated.
For more information, contact your gastroentomologist or consult your gastrodiagnostic team.
SOURCE Medscape Medscape Pharmaceuticals, Inc. Medscape Pharmapackage Medscape Pts., Pts.
(Medscape MedTech), Medscape Health, Inc., Medscape Care, Inc.; 2016-04-18 (CNA).
Medscape Health (NASDAQ: MEDCY) is a leading provider of high-quality prescription drugs, specialty medical products, biotechnology and biotechnology-related research products, and clinical services, and has a global network of over 2,000 physicians and researchers who provide healthcare professionals with access to leading pharmaceutical, biotechnological, medical device, clinical research and medical device-related products.
MedScape is a wholly-owned subsidiary of Medscape.
MedScan is the exclusive supplier of diagnostic imaging and related technology to healthcare providers in the United States, Canada and Mexico.
MedScape’s medical device portfolio includes the MedScan Diagnostics, the MedScapes Therapeutic, and MedScenes Therapeutics medical devices, the Medicis BioScan, the Mabs BioScan and the Medici BioScan clinical devices.
MedCyn is a healthcare technology company that develops and delivers innovative solutions to healthcare.
MedTech is a provider of healthcare technologies for pharmaceutical and biotechetical devices.
SOURCE MedTechMedics, IncMedTechMedICS, Inc.(NYSE: MEDICY)MedTech Medical Technologies,